From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations
29.5.2026 15:00:00 CEST | Business Wire | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises.
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise.
Early customer outcomes show the magnitude of the shift:
- A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes.
- A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%.
- A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall problem, delivering both the correct diagnosis and the specific commands to remediate.
"NetBrain is enabling our customers to achieve Agentic NetOps in production today," said Bernadette Nixon, CEO of NetBrain Technologies. "Our agents are not simply AI assistants, but act as operators that diagnose, decide, and act, governed by the verified network grounding our platform provides. We are delivering on both the innovative, purpose-built Agents and a platform to provide the trusted network context that allows our customers to pursue automation confidently."
Why Agentic NetOps, and why now
Networks are where most enterprises place blame first for issues, and where AI built on event correlation alone consistently fails. Agentic NetOps requires more than inference: it requires verified, current network state, intent validation, and path intelligence that no telemetry stream can produce. Gartner® predicts that, “By the end of 2027, 80% of network automation platform vendors will introduce agentic AI capabilities that enable probabilistic automation, up from less than 20% in early 2026.”*
NetBrain's network context model spanning Device, Topology, Path, and Intent across 150+ hardware vendors is the proprietary foundation that makes autonomous network operations possible. Available June 1, these new features extend the NetBrain platform:
- AI Path Doctor: Validates network paths, flags inaccuracies, and generates runbooks to remediate. Reliable paths are the precondition for every diagnosis and automation the agents run.
- Agent Skills: Institutional knowledge and best practices captured as Agent Skills tailoring NetBrain Agents to each customer's environment – without writing code or retraining models.
- Cross-Domain Context: New integrations consume application and infrastructure context from ITSM, security, and APM platforms, including Dynatrace, into NetBrain's diagnosis workflow, resolving the "is it the network or the application" question and eliminating 40% or more of tickets.
- Golden Assessment Library 26.06: Pre-built, industry-validated network assessments released on a regular basis to help stay abreast of industry shifts. This release includes updated coverage for capacity management, Cisco ACI intent integration with Deep Diagnosis, and Troubleshooting Skills for Deep Diagnosis.
- LLM Flexibility and MCP Support: Native support for Claude, Gemini, GPT, and any OpenAI-compatible endpoint including self-hosted models. Through MCP, NetBrain's network intelligence is now available to the broader agentic enterprise, extending NetBrain's grounded truth to whatever AI platforms our customers operate alongside it.
"The agentic conversation has been dominated by model choice and agent design and on ticket and log analysis use cases. The key to unlock adoption is grounded network truth that informs diagnosis and a remediation plan – for a real fix to real customer problems," said Song Pang, CTO of NetBrain Technologies. "Agent Skills tailor our agents to each customer's environment. AI Path Doctor guarantees path accuracy. MCP ties in the rest of the AI ecosystem. Together, they enable immediate business value and close the loop from diagnosis to remediation, at machine speed, with human confidence."
"Agentic NetOps software goes beyond assistants and chatbots that retrieve and suggest but depend on humans to decide what actions to take. Agentic network operations software interprets goals, plans, reasons, acts, and verifies under guardrails."**
Gartner
From category to roadmap
NetBrain's Deep Diagnosis and Runbook Companion agents, released earlier this year, are deployed at hundreds of enterprises automating fault isolation and guided remediation. Both are now significantly more capable through MCP and Agent Skills, and the expanded platform foundation accelerates NetBrain's delivery of additional agents on the roadmap.
Customers leverage NetBrain from planning to change to day-2 network operations, employing human-in-the-loop to human-on-the-loop to human-out-of-the-loop diagnosis, assessment, and change. NetBrain works with customers to build their path to agentic NetOps that delivers measurable ROI at every stage.
These enhancements to the NetBrain platform are available June 1, 2026. Learn more at https://www.netbrain.com/platform/journey-to-agentic-netops/?utm_source=businesswire&utm_medium=text_link&utm_campaign=jtano_q2fy26_integrated.
At Cisco Live, Las Vegas, June 1-4: Join NetBrain at the Zero Outage Lounge (Mandalay Bay Suite, May 31-June 4) and at the Race to Agentic NetOps event (Grand Prix Plaza, June 2, 7-10 PM).
NetBrain Live, Boston, September 22-24, 2026: Registration is open. NetBrain will unveil a full suite of agents built on the context platform spanning diagnosis, remediation, change management, validation, and assessment. Learn more at netbrain.com/netbrain-live?utm_source=businesswire&utm_medium=text_link&utm_campaign=jtano_q2fy26_integrated.
*Gartner, Market Guide for Network Automation Platforms, 29 April 2026. GARTNER is a trademark of Gartner, Inc. and/or its affiliates.
**Gartner, Innovation Insight: Agentic NetOps Software Redefines Networking, 18 February 2026.
About NetBrain Technologies
NetBrain pioneers Agentic NetOps, delivering autonomous network operations through AI agents that diagnose, decide, and act with full network context. NetBrain serves approximately one third of the Fortune 100 and Fortune 500 across the most complex enterprise networks in the world, with offices in Boston, London, Hyderabad, Beijing, and Toronto.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260529011510/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
Meilleurtaux Accelerates AI Strategy as First Broker to Launch Mortgage Lending App on ChatGPT in France29.5.2026 09:00:00 CEST | Press release
Dedicated channel enables hundreds of millions of users to simulate their borrowing capacity and facilitate loan applications directly within ChatGPT’s interfaceNew milestone in “AI First” strategy gives French consumers greater control of their financial future. Meilleurtaux, a leading omnichannel financial services brokerage platform (credit, insurance, investments), announced today the launch of a dedicated mortgage lending app directly within ChatGPT, OpenAI’s artificial intelligence platform, which now has several hundred million active users worldwide. With this new service, Meilleurtaux reaches another milestone in its “AI First” strategy and reinforces its commitment to supporting French consumers in the adoption of artificial intelligence. Simulating a Mortgage in ChatGPT: Simple, Fast, No Forms Required Until now, obtaining a borrowing capacity simulation meant browsing a website, filling out forms, and waiting for a response. Meilleurtaux has changed that: users can now run
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom